Ferroptosis and recurrent miscarriage: a critical review of pathophysiology and emerging therapeutic targets
Ferroptosis is characterized as a specialized type of regulated cellular death that relies on iron and lipid peroxidation, which has recently been highlighted as playing a crucial role in the etiology of recurrent miscarriage (RM). Ferroptosis in RM is driven by dysregulated iron metabolism and incr...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Cell and Developmental Biology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2025.1559300/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849727107425370112 |
|---|---|
| author | Mohammad Masoud Khodaei Zahra Noori Fateme Zare Ahmad Meshkin |
| author_facet | Mohammad Masoud Khodaei Zahra Noori Fateme Zare Ahmad Meshkin |
| author_sort | Mohammad Masoud Khodaei |
| collection | DOAJ |
| description | Ferroptosis is characterized as a specialized type of regulated cellular death that relies on iron and lipid peroxidation, which has recently been highlighted as playing a crucial role in the etiology of recurrent miscarriage (RM). Ferroptosis in RM is driven by dysregulated iron metabolism and increased oxidative stress, resulting from impaired antioxidant defense, which leads to lipid peroxidation and consequent cell death in trophoblasts. The cellular changes compromise placental development and impair trophoblast invasion and maternal-fetal tolerance. Therapeutic interventions targeting ferroptosis are promising for the mitigation of its effects and improvement of pregnancy outcomes. Strategies include Glutathione Peroxidase 4 (GPX4) activity enhancement, glutathione replenishment, ferroptosis inhibitors, and iron metabolism modulation. Further, new strategies targeting non-coding RNAs, and epigenetic regulators emphasize ferroptosis as a viable therapeutic target. This review emphasizes the importance of ferroptosis in the pathophysiology of RM and highlights its potential for guiding innovative treatments. |
| format | Article |
| id | doaj-art-86226c2bcfd14da79512f6566f61e703 |
| institution | DOAJ |
| issn | 2296-634X |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cell and Developmental Biology |
| spelling | doaj-art-86226c2bcfd14da79512f6566f61e7032025-08-20T03:09:57ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2025-06-011310.3389/fcell.2025.15593001559300Ferroptosis and recurrent miscarriage: a critical review of pathophysiology and emerging therapeutic targetsMohammad Masoud KhodaeiZahra NooriFateme ZareAhmad MeshkinFerroptosis is characterized as a specialized type of regulated cellular death that relies on iron and lipid peroxidation, which has recently been highlighted as playing a crucial role in the etiology of recurrent miscarriage (RM). Ferroptosis in RM is driven by dysregulated iron metabolism and increased oxidative stress, resulting from impaired antioxidant defense, which leads to lipid peroxidation and consequent cell death in trophoblasts. The cellular changes compromise placental development and impair trophoblast invasion and maternal-fetal tolerance. Therapeutic interventions targeting ferroptosis are promising for the mitigation of its effects and improvement of pregnancy outcomes. Strategies include Glutathione Peroxidase 4 (GPX4) activity enhancement, glutathione replenishment, ferroptosis inhibitors, and iron metabolism modulation. Further, new strategies targeting non-coding RNAs, and epigenetic regulators emphasize ferroptosis as a viable therapeutic target. This review emphasizes the importance of ferroptosis in the pathophysiology of RM and highlights its potential for guiding innovative treatments.https://www.frontiersin.org/articles/10.3389/fcell.2025.1559300/fullferroptosisrecurrent miscarriage (RM)therapeutic interventionstrophoblast dysfunctionglutathione peroxidase 4 |
| spellingShingle | Mohammad Masoud Khodaei Zahra Noori Fateme Zare Ahmad Meshkin Ferroptosis and recurrent miscarriage: a critical review of pathophysiology and emerging therapeutic targets Frontiers in Cell and Developmental Biology ferroptosis recurrent miscarriage (RM) therapeutic interventions trophoblast dysfunction glutathione peroxidase 4 |
| title | Ferroptosis and recurrent miscarriage: a critical review of pathophysiology and emerging therapeutic targets |
| title_full | Ferroptosis and recurrent miscarriage: a critical review of pathophysiology and emerging therapeutic targets |
| title_fullStr | Ferroptosis and recurrent miscarriage: a critical review of pathophysiology and emerging therapeutic targets |
| title_full_unstemmed | Ferroptosis and recurrent miscarriage: a critical review of pathophysiology and emerging therapeutic targets |
| title_short | Ferroptosis and recurrent miscarriage: a critical review of pathophysiology and emerging therapeutic targets |
| title_sort | ferroptosis and recurrent miscarriage a critical review of pathophysiology and emerging therapeutic targets |
| topic | ferroptosis recurrent miscarriage (RM) therapeutic interventions trophoblast dysfunction glutathione peroxidase 4 |
| url | https://www.frontiersin.org/articles/10.3389/fcell.2025.1559300/full |
| work_keys_str_mv | AT mohammadmasoudkhodaei ferroptosisandrecurrentmiscarriageacriticalreviewofpathophysiologyandemergingtherapeutictargets AT zahranoori ferroptosisandrecurrentmiscarriageacriticalreviewofpathophysiologyandemergingtherapeutictargets AT fatemezare ferroptosisandrecurrentmiscarriageacriticalreviewofpathophysiologyandemergingtherapeutictargets AT ahmadmeshkin ferroptosisandrecurrentmiscarriageacriticalreviewofpathophysiologyandemergingtherapeutictargets |